Clinical importance of an elevated circulating chemerin level in incident dialysis patients

CHEMERIN IS AN INDEPENDENT MARKER OF THE METABOLIC SYNDROME IN A CAUCASIAN POPULATION - A PILOT STUDY

(2012) David Stejskal et al.   BIOMEDICAL PAPERS-OLOMOUC

Identification of chemerin receptor (ChemR23) in human endothelial cells: Chemerin-induced endothelial angiogenesis

(2010) Jaspreet Kaur et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

PET Imaging of Leptin Biodistribution and Metabolism in Rodents and Primates

(2009) Giovanni Ceccarini et al.   Cell Metabolism

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes

(2009) Johanna Weigert et al.   CLINICAL ENDOCRINOLOGY

Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells

(2009) Henrike Sell et al.   DIABETES

Serum Levels of the Adipokine Chemerin in Relation to Renal Function

(2009) D. Pfau et al.   DIABETES CARE

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

(2009) Michael Lehrke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population

(2009) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients

(2009) M. Chmielewski et al.   JOURNAL OF INTERNAL MEDICINE

Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease

(2009) S. Beddhu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Elevated Gamma-Glutamyltransferase Activity and Perturbed Thiol Profile Are Associated With Features of Metabolic Syndrome

(2008) Philippe Giral et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients

(2008) Alessandro Valli et al.   CLINICA CHIMICA ACTA

The link between abdominal obesity and the metabolic syndrome

(2008) Liza K. Phillips et al.   CURRENT HYPERTENSION REPORTS

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

(2008) G. R. Hajer et al.   EUROPEAN HEART JOURNAL

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

(2008) Michiko Takahashi et al.   FEBS LETTERS

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

(2008) Jenna L. Cash et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Resolved: Being Fat Is Good for Dialysis Patients: The Godzilla Effect: Pro

(2008) T. A. Ikizler et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The emerging biology of adipose tissue in chronic kidney disease: from fat to facts

(2008) J. Axelsson   NEPHROLOGY DIALYSIS TRANSPLANTATION

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

(2007) D. Fouque et al.   KIDNEY INTERNATIONAL